PDF(Pubmed)
Abstract：
OBJECTIVE: We established an orthopedic ward fracture liaison services (OWFLS) model and evaluated its role in improving detection rates of bone metabolic markers, treatment rates, and long-term treatability.
METHODS: This observational retrospective cohort study included 120 patients aged >50 years hospitalized for primary osteoporotic fracture from January 2018 to January 2019 (group A: not included in OWFLS). Group B (included in OWFLS) comprised 120 patients from February 2019 to February 2020. We compared rates of bone metabolic index testing, treatment, and adherence; symptomatic improvement; and recurrent fracture between groups.
RESULTS: Rates of bone metabolism index testing (50% vs. 0%) and medication use (94.2% vs. 64.2%) were significantly higher after OWFLS implementation. There was no significant difference in adherence rates at 3 months between groups (97.3% vs. 93.5%). Adherence rates at 1 and 3 years were better in group B than A (73.5% vs. 51.9%; 57.5% vs. 26%, respectively). Recurrence of bone pain at 1 and 3 years was significantly lower in group B than A (20.4% vs. 46.8%; 45.1% vs. 76.6%, respectively).
CONCLUSIONS: OWFLS improved the detection rate of bone metabolism indicators, treatment rate, and patient adherence and reduced recurrence of bone pain. OWFLS may be suitable for settings lacking human resources.
METHODS: This observational retrospective cohort study included 120 patients aged >50 years hospitalized for primary osteoporotic fracture from January 2018 to January 2019 (group A: not included in OWFLS). Group B (included in OWFLS) comprised 120 patients from February 2019 to February 2020. We compared rates of bone metabolic index testing, treatment, and adherence; symptomatic improvement; and recurrent fracture between groups.
RESULTS: Rates of bone metabolism index testing (50% vs. 0%) and medication use (94.2% vs. 64.2%) were significantly higher after OWFLS implementation. There was no significant difference in adherence rates at 3 months between groups (97.3% vs. 93.5%). Adherence rates at 1 and 3 years were better in group B than A (73.5% vs. 51.9%; 57.5% vs. 26%, respectively). Recurrence of bone pain at 1 and 3 years was significantly lower in group B than A (20.4% vs. 46.8%; 45.1% vs. 76.6%, respectively).
CONCLUSIONS: OWFLS improved the detection rate of bone metabolism indicators, treatment rate, and patient adherence and reduced recurrence of bone pain. OWFLS may be suitable for settings lacking human resources.
摘要：
目的：我们建立了骨科病房骨折联络服务（OWFLS）模型，并评估了其在提高骨代谢标志物检出率中的作用，治疗率,和长期治疗。
方法：本观察性回顾性队列研究纳入了2018年1月至2019年1月因原发性骨质疏松性骨折住院的120例年龄>50岁的患者（A组：未纳入OWFLS）。B组（包括OWFLS）包括2019年2月至2020年2月的120名患者。我们比较了骨代谢指标测试的比率，治疗,和依从性；症状改善；组间复发性骨折。
结果：骨代谢指标测试率（50%vs.0%）和药物使用（94.2%vs.64.2%)显著高于OWFLS实施后。组间3个月的依从率无显著差异（97.3%vs.93.5%）。B组1年和3年的依从率优于A组（73.5%vs.51.9%；57.5%与26%,分别)。B组1年和3年的骨痛复发明显低于A组（20.4%vs.46.8%；45.1%与76.6%,分别)。
结论：OWFLS提高了骨代谢指标的检出率，治疗率,和患者的依从性和减少骨痛的复发。OWFLS可能适用于缺乏人力资源的环境。
方法：本观察性回顾性队列研究纳入了2018年1月至2019年1月因原发性骨质疏松性骨折住院的120例年龄>50岁的患者（A组：未纳入OWFLS）。B组（包括OWFLS）包括2019年2月至2020年2月的120名患者。我们比较了骨代谢指标测试的比率，治疗,和依从性；症状改善；组间复发性骨折。
结果：骨代谢指标测试率（50%vs.0%）和药物使用（94.2%vs.64.2%)显著高于OWFLS实施后。组间3个月的依从率无显著差异（97.3%vs.93.5%）。B组1年和3年的依从率优于A组（73.5%vs.51.9%；57.5%与26%,分别)。B组1年和3年的骨痛复发明显低于A组（20.4%vs.46.8%；45.1%与76.6%,分别)。
结论：OWFLS提高了骨代谢指标的检出率，治疗率,和患者的依从性和减少骨痛的复发。OWFLS可能适用于缺乏人力资源的环境。
